$MED
MEDIFAST INC

2019 Q2 Form 10-Q Financial Statement

#000155837019006948 Filed on August 02, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q2
Revenue $187.1M $117.3M
YoY Change 59.48% 54.93%
Cost Of Revenue $46.39M $28.53M
YoY Change 62.64% 57.6%
Gross Profit $140.7M $88.80M
YoY Change 58.46% 54.14%
Gross Profit Margin 75.2% 75.69%
Selling, General & Admin $113.4M $71.69M
YoY Change 58.12% 54.84%
% of Gross Profit 80.56% 80.73%
Research & Development $500.0K
YoY Change
% of Gross Profit 0.36%
Depreciation & Amortization $1.100M $1.200M
YoY Change -8.33% 20.0%
% of Gross Profit 0.78% 1.35%
Operating Expenses $113.4M $71.69M
YoY Change 58.12% 54.84%
Operating Profit $27.36M $17.11M
YoY Change 59.88% 51.27%
Interest Expense $425.0K $330.0K
YoY Change 28.79% 230.0%
% of Operating Profit 1.55% 1.93%
Other Income/Expense, Net $423.0K $509.0K
YoY Change -16.9%
Pretax Income $27.78M $17.62M
YoY Change 57.66% 53.9%
Income Tax $6.395M $3.486M
% Of Pretax Income 23.02% 19.79%
Net Earnings $21.38M $14.13M
YoY Change 51.3% 86.35%
Net Earnings / Revenue 11.43% 12.05%
Basic Earnings Per Share $1.80 $1.17
Diluted Earnings Per Share $1.75 $1.16
COMMON SHARES
Basic Shares Outstanding 11.86M 12.04M
Diluted Shares Outstanding 12.22M 12.17M

Balance Sheet

Concept 2019 Q2 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $209.8M $103.3M
YoY Change 103.13% 16.59%
Cash & Equivalents $96.31M $81.08M
Short-Term Investments $113.5M $22.20M
Other Short-Term Assets $7.600M $3.900M
YoY Change 94.87% 21.88%
Inventory $48.47M $26.90M
Prepaid Expenses
Receivables $978.0K $900.0K
Other Receivables $1.300M $0.00
Total Short-Term Assets $172.0M $135.1M
YoY Change 27.3% 22.04%
LONG-TERM ASSETS
Property, Plant & Equipment $24.98M $18.20M
YoY Change 37.27% -1.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $710.0K $3.000M
YoY Change -76.33% 900.0%
Total Long-Term Assets $40.60M $21.20M
YoY Change 91.49% 12.77%
TOTAL ASSETS
Total Short-Term Assets $172.0M $135.1M
Total Long-Term Assets $40.60M $21.20M
Total Assets $212.6M $156.3M
YoY Change 36.0% 20.69%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $73.60M $53.40M
YoY Change 37.83% 112.75%
Accrued Expenses $2.500M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $76.04M $53.40M
YoY Change 42.4% 112.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $10.50M
YoY Change
Total Long-Term Liabilities $10.50M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $76.04M $53.40M
Total Long-Term Liabilities $10.50M $0.00
Total Liabilities $86.55M $53.40M
YoY Change 62.07% 111.07%
SHAREHOLDERS EQUITY
Retained Earnings $155.8M
YoY Change
Common Stock $12.00K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $126.0M $102.9M
YoY Change
Total Liabilities & Shareholders Equity $212.6M $156.3M
YoY Change 36.0% 20.69%

Cashflow Statement

Concept 2019 Q2 2018 Q2
OPERATING ACTIVITIES
Net Income $21.38M $14.13M
YoY Change 51.3% 86.35%
Depreciation, Depletion And Amortization $1.100M $1.200M
YoY Change -8.33% 20.0%
Cash From Operating Activities $14.50M $20.50M
YoY Change -29.27% 46.43%
INVESTING ACTIVITIES
Capital Expenditures -$2.600M -$800.0K
YoY Change 225.0% 60.0%
Acquisitions
YoY Change
Other Investing Activities $1.400M $200.0K
YoY Change 600.0% -200.0%
Cash From Investing Activities -$1.100M -$600.0K
YoY Change 83.33% -14.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -18.90M -25.80M
YoY Change -26.74% 578.95%
NET CHANGE
Cash From Operating Activities 14.50M 20.50M
Cash From Investing Activities -1.100M -600.0K
Cash From Financing Activities -18.90M -25.80M
Net Change In Cash -5.500M -5.900M
YoY Change -6.78% -162.11%
FREE CASH FLOW
Cash From Operating Activities $14.50M $20.50M
Capital Expenditures -$2.600M -$800.0K
Free Cash Flow $17.10M $21.30M
YoY Change -19.72% 46.9%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0000910329
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-31573
dei Entity Registrant Name
EntityRegistrantName
Medifast, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3714405
dei Entity Address Address Line1
EntityAddressAddressLine1
100 International Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Baltimore
dei Entity Address State Or Province
EntityAddressStateOrProvince
MD
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
21202
dei City Area Code
CityAreaCode
410
dei Local Phone Number
LocalPhoneNumber
581-8042
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
178000
CY2019Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
423000
CY2018Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
509000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
729000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
757000
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MED
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11836334
CY2019Q2 us-gaap Revenues
Revenues
187103000
CY2018Q2 us-gaap Revenues
Revenues
117324000
us-gaap Revenues
Revenues
352979000
us-gaap Revenues
Revenues
215920000
CY2019Q2 us-gaap Cost Of Revenue
CostOfRevenue
46393000
CY2018Q2 us-gaap Cost Of Revenue
CostOfRevenue
28525000
us-gaap Cost Of Revenue
CostOfRevenue
87122000
us-gaap Cost Of Revenue
CostOfRevenue
52313000
CY2019Q2 us-gaap Gross Profit
GrossProfit
140710000
CY2018Q2 us-gaap Gross Profit
GrossProfit
88799000
us-gaap Gross Profit
GrossProfit
265857000
us-gaap Gross Profit
GrossProfit
163607000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
113355000
CY2018Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
71689000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
213787000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131814000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
27355000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
17110000
us-gaap Operating Income Loss
OperatingIncomeLoss
52070000
us-gaap Operating Income Loss
OperatingIncomeLoss
31793000
CY2019Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
425000
CY2018Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
330000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
737000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
579000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
179000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27778000
CY2018Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
17619000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
52799000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
32550000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6395000
CY2018Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3486000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10666000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6195000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-59000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
19670000
CY2019Q2 us-gaap Prepaid Taxes
PrepaidTaxes
1365000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
102000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
229000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-59000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21485000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14158000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
42362000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
26296000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
us-gaap Net Income Loss
NetIncomeLoss
42133000
us-gaap Net Income Loss
NetIncomeLoss
26355000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.75
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11861000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12037000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11870000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12032000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12218000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12229000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12129000
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.75
CY2018Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.48
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.50
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.96
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
us-gaap Net Income Loss
NetIncomeLoss
42133000
us-gaap Net Income Loss
NetIncomeLoss
26355000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1000
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
102000
CY2018Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
25000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
228000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96311000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81364000
CY2019Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
931000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
394000
CY2019Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
978000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1011000
CY2019Q2 us-gaap Inventory Net
InventoryNet
48473000
CY2018Q4 us-gaap Inventory Net
InventoryNet
38888000
CY2019Q2 us-gaap Short Term Investments
ShortTermInvestments
17211000
CY2019Q2 us-gaap Liabilities
Liabilities
86548000
CY2018Q4 us-gaap Liabilities
Liabilities
60323000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7638000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4586000
CY2019Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40877000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2474000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
76044000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
60323000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10504000
CY2018Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
193000
us-gaap Share Based Compensation
ShareBasedCompensation
1635000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-17000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
171976000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
145519000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
24984000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19747000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
12296000
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
710000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1183000
CY2019Q2 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2605000
CY2018Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
2980000
CY2019Q2 us-gaap Assets
Assets
212571000
CY2018Q4 us-gaap Assets
Assets
169429000
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
73570000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60323000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12126000
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12117000
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11827000
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11868000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
12000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
12000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
11070000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8802000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
155762000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
131344000
CY2019Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
264000
CY2018Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
30879000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
126023000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
212571000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
169429000
us-gaap Net Income Loss
NetIncomeLoss
42133000
us-gaap Net Income Loss
NetIncomeLoss
26355000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2156000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2689000
us-gaap Share Based Compensation
ShareBasedCompensation
2245000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
19996000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27724000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-50000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-8000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-31822000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14947000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-35000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-33000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
13963000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11958000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
47212000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38531000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
2430000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
1200000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
184000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5999000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81364000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
75077000
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
21000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
249000
med Amortization Of Premium On Investment Securities
AmortizationOfPremiumOnInvestmentSecurities
298000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
375000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1036000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-33000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-199000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9585000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6670000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1365000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
2673000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3052000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-368000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6972000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2094000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4542000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-710000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
279000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
256000
us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
215000
us-gaap Payments Of Dividends
PaymentsOfDividends
17749000
us-gaap Payments Of Dividends
PaymentsOfDividends
11673000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9998000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
96311000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
81076000
us-gaap Income Taxes Paid
IncomeTaxesPaid
11338000
us-gaap Income Taxes Paid
IncomeTaxesPaid
4380000
us-gaap Dividends Cash
DividendsCash
9102000
us-gaap Dividends Cash
DividendsCash
5914000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
109106000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
20750000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
990000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
269000
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
256000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
113630000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
127000
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8918000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
122068000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
1255000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10000
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
102000
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9998000
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8797000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
126023000
CY2017Q4 us-gaap Cumulative Effect Of New Accounting Principle In Period Of Adoption
CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption
-2018000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
106563000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
12222000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
805000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
62000
CY2018Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
215000
CY2018Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-84000
CY2018Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5723000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
830000
CY2018Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
19996000
CY2018Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
25000
CY2018Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
5759000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
102863000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;">Use of Estimates</b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting period. Actual results could differ materially from those estimates.</p>
CY2019Q2 us-gaap Inventory Net
InventoryNet
48473000
CY2018Q4 us-gaap Inventory Net
InventoryNet
38888000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
21383000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
14133000
us-gaap Net Income Loss
NetIncomeLoss
42133000
us-gaap Net Income Loss
NetIncomeLoss
26355000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11861000
CY2019Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
11204000
CY2018Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
11156000
CY2019Q2 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
2264000
CY2018Q4 us-gaap Retail Related Inventory Packaging And Other Supplies
RetailRelatedInventoryPackagingAndOtherSupplies
1563000
CY2019Q2 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
5186000
CY2018Q4 med Inventory Non Food Finished Goods
InventoryNonFoodFinishedGoods
2391000
CY2019Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
32474000
CY2018Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25509000
CY2019Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2655000
CY2018Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1731000
CY2018Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12037000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11870000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12032000
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
357000
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
137000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
359000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
97000
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12218000
CY2018Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12174000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12229000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12129000
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.80
CY2018Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.19
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.75
CY2018Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.45
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.17
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
26.52
us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
171.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0262
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.3330
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0287
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.08
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
279000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
62000
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1300000
CY2018Q2 us-gaap Share Based Compensation
ShareBasedCompensation
830000
us-gaap Share Based Compensation
ShareBasedCompensation
2200000
us-gaap Share Based Compensation
ShareBasedCompensation
1600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y3M
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
726000
us-gaap Operating Lease Cost
OperatingLeaseCost
1400000
CY2019Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2019Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
729000
us-gaap Operating Lease Payments
OperatingLeasePayments
1392000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1490000
CY2019Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y2M12D
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1462000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2951000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2985000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2641000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1665000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2685000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14389000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1411000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
12978000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1496000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1528000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1562000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1222000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1155000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
2582000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
9545000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-2000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
57000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-171000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
56000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-173000
CY2019Q2 us-gaap Marketable Securities
MarketableSecurities
113262000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
9000
CY2019Q2 us-gaap Interest Receivable
InterestReceivable
269000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
113522000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
96311000
CY2019Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
17211000
CY2018Q4 us-gaap Marketable Securities
MarketableSecurities
100990000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Before Tax1
AccumulatedOtherComprehensiveIncomeLossBeforeTax1
236000
CY2018Q4 us-gaap Interest Receivable
InterestReceivable
280000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
101034000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81364000
CY2018Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
19670000
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2018Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0
CY2019Q2 us-gaap Debt And Equity Securities Realized Gain Loss
DebtAndEquitySecuritiesRealizedGainLoss
0

Files In Submission

Name View Source Status
0001558370-19-006948-index-headers.html Edgar Link pending
0001558370-19-006948-index.html Edgar Link pending
0001558370-19-006948.txt Edgar Link pending
0001558370-19-006948-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
med-20190630.xsd Edgar Link pending
med-20190630ex3116e41a2.htm Edgar Link pending
med-20190630ex3120eff47.htm Edgar Link pending
med-20190630ex321c55eee.htm Edgar Link pending
med-20190630x10q.htm Edgar Link pending
med-20190630x10q_htm.xml Edgar Link completed
med-20190630_cal.xml Edgar Link unprocessable
med-20190630_def.xml Edgar Link unprocessable
med-20190630_lab.xml Edgar Link unprocessable
med-20190630_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending